In the current study, we evaluated the frequency of 20 recurrent mutations in six genes (BRCA1, BRCA2, CHEK2, PALB2, NBN and RECQL) in 165 men diagnosed with breast cancer in Poland. The gene discussed is CHEK2; the disease is breast cancer.